ImmunoPET Targeting Trophoblast Cell-surface Antigen 2 (Trop-2) in Craniopharyngioma Patients

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 4, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Craniopharyngioma
Interventions
DIAGNOSTIC_TEST

68Ga-MY6349 PET/CT

Each subject receives a single intravenous injection of 68Ga-MY6349 and undergoes PET/CT imaging within the specified time.

Trial Locations (1)

100070

RECRUITING

Beijing Tiantan Hospital, Beijing

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Peking Union Medical College Hospital

OTHER

lead

Deling Li

OTHER

NCT07177482 - ImmunoPET Targeting Trophoblast Cell-surface Antigen 2 (Trop-2) in Craniopharyngioma Patients | Biotech Hunter | Biotech Hunter